Skip to: Curated Story Group 1
lifesciencesreview

Advertise

with us

  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Topics
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Business Services
    Business Services
    Business Services
    Business Services
    Business Services
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Pharmacy Management
    Regulatory Services
  • CXO Insights
  • Vendor Viewpoint
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • CXO Awards
JULY 2024LIFE SCIENCES REVIEW9loss of not analyzing the variability from exposing different cells to multiple physicochemical conditions and understanding how the phenotype would react. Think, for example, of Diabetes. In most type 1 cases, people inherit risk factors from both parents, but no single gene causes the characteristic sustained high blood sugar levels. Researchers are studying potential environmental triggers such as weather, viruses or even early diet, showing that a genomic analysis would be insufficient. The same is true for more than one type of cancer. Having a genetic predisposition is not the same as a diagnostic. That's why taking into account multiple sources of information about patients and their tendencies can inform us about varying susceptibility to environmental triggers. That is why Multi-Omics technologies enter the picture. By combining bioinformatics, computer science, and machine learning methods, we can benefit from the array of them available. It is not just a matter of evaluating base pairs. We must consider protein production, chaotic interactions, and associated specific metabolic pathways. Biology involves the entire living world and is, therefore, infinite. DNA sequencing and other biological techniques will continue to increase the number and complexity of gene data sets. Having a Multi-Omics database is more than a matter of scientific curiosity. It is a necessary repository in case you truly want to understand what goes on inside living entities. That is why researchers need Artificial intelligence (AI) or machine learning-based computational tools that can handle, extract, and interpret the valuable information hidden within this trove of data. In this way, mathematical models for AI would bring us closer to a global understanding of how environmental conditions affect cell output. Multi-Omic data can fuel AI models, surpassing the results of analyzing a single Omic. Each provides variability that a machine learning model could learn to simulate unseen states of a cell before going to the lab. Processing Multi-Omic data with AI saves time, reveals new patterns in the data that are unobservable by the naked eye, allows searching for biomarkers, finding new cell subtypes, understanding the performance of different cell lines in bioprocesses, or studying cell differentiation in stem cells. With Multi-Omics analysis platforms, we could abandon plain metaphors that conceive DNA as the blueprint of living things to more accurate models, far removed from educational oversimplifications. A new field of opportunity is created due to Multi-Omics analysis platforms, increasing the speed and amount of data analysis. Many laboratories can benefit from this type of advance to generate more discoveries and speed up decision-making in trials. These advances have a relevant impact on academia and industry, two sectors constantly feeding back into each other. Whatever sector you are in, one thing is clear today: a single Omic falls short of understanding the complexity of life. A new field of opportunity is created due to Multi-Omics analysis platforms, increasing the speed and amount of data analysis. Many laboratories can benefit from this type of advance to generate more discoveries and speed up decision-making in trials
< Page 8 | Page 10 >